Inflammatory protein responsible for obesity-linked diseases unveiledApril 8th, 2009 - 1:10 pm ICT by ANI
Washington, Apr 8 (ANI): An inflammatory factor-already implicated in causing several diseases, like pulmonary disease, lung cancer, and arthritis- may also have a role to play in insulin resistance linked with obesity, according to a study.
The researchers behind the study say that an inflammatory protein, known as CXCL5, rises and falls with obesity and subsequent weight loss in humans.
They say that they experiments on mice have provided further evidence linking the inflammatory factor, which is produced and secreted at high levels by fat tissue, to insulin resistance.
The researchers have also shown that treatments designed to block its action improve the animals’ sensitivity to insulin.
“Clearly, this finding could be a big development for understanding the side effects of obesity. It offers a new target for therapy and new hope for subjects to improve their pathology,” said Lluis Fajas of INSERM in France.
The researchers explained that fat tissue known as white adipose tissue (WAT) is primarily involved in energy storage in the form of triglycerides and energy release in the form of free fatty acids.
WAT, however, is more than a fat storage organ-it also secretes numerous other factors with roles in both health and disease.
In the current study, the researchers showed that CXCL5 is one of those factors, for it is expressed at high levels in WAT, particularly in immune cells known as macrophages.
They also claimed that CXCL5 is dramatically increased in the blood of people who are obese as compared to those who are lean.
The CXCL5 levels drop when obese people lose weight and are also lower in obese individuals that continue to respond to insulin than in those who are insulin resistant.
The researchers further found that treatment with recombinant CXCL5 blocks insulin-stimulated glucose uptake in the muscles of mice.
The mice lacking the CXCL5 receptor were also protected against obesity-induced insulin resistance.
Overall, the findings showed that CXCL5 produced by fat tissue “represents a link between obesity, inflammation, and insulin resistance.”
Interestingly, the researchers said that the CXCR2 receptor was active outside of muscle, and thus increased levels of the chemokine as observed in obesity could lead to other problems, including atherosclerosis and other inflammatory diseases.
The study has been published in the latest issue of Cell Metabolism, a Cell Press publication. (ANI)
- Molecule that makes obese people develop diabetes discovered - Nov 25, 2009
- Micro-RNA that regulates insulin in obesity identified - Apr 01, 2011
- A missing link from obesity to infertility discovered - Sep 12, 2010
- Link between high-fat diets, type 2 diabetes clarified - Apr 12, 2011
- Brain insulin plays critical role in development of diabetes - Feb 17, 2011
- Low testosterone levels could cause diabetes - May 06, 2012
- Chronic inhalation of polluted air 'can lead to inflammation, heart risk' - Apr 17, 2011
- Potential new non-insulin treatment for type 1 diabetes found - Mar 25, 2011
- Potential new target for diabetes, heart disease treatments identified - Nov 17, 2010
- New discovery may help reduce obesity complications - Feb 04, 2010
- Birch bark ingredient has an array of metabolic benefits - Jan 05, 2011
- Missing sugar molecule 'increases diabetes risk' - Feb 25, 2011
- How fish oils work against diabetes - Sep 03, 2010
- Obesity may protect against metabolic syndrome - Mar 09, 2010
- Apple compound may help burn fat, reduce obesity - Jun 21, 2012
Tags: effects of obesity, energy release, energy storage, fajas, free fatty acids, glucose uptake, immune cells, inflammatory protein, inserm, insulin resistance, lung cancer, macrophages, mice, new hope, obese individuals, pulmonary disease, side effects of obesity, target, triglycerides, white adipose tissue